Developing a new brain imaging technology for better diagnosis and treatment of neurological diseases
Ultra-High Performance Brain-dedicated PET scanner for Neurology and Neuro-oncology imaging
['FUNDING_R01'] · WEILL MEDICAL COLL OF CORNELL UNIV · NIH-10893579
This study is working on a super advanced brain scanner that helps doctors see and understand brain diseases like Alzheimer's and brain tumors better, which could lead to earlier diagnoses and more effective treatments for patients.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | WEILL MEDICAL COLL OF CORNELL UNIV (nih funded) |
| Locations | 1 site (NEW YORK, UNITED STATES) |
| Trial ID | NIH-10893579 on ClinicalTrials.gov |
What this research studies
This research focuses on creating an ultra-high performance brain-dedicated PET scanner that significantly improves the imaging of neurological and neuro-oncological conditions. By enhancing spatial resolution and sensitivity, this technology aims to detect and track small changes in brain regions associated with diseases like Alzheimer's and improve the accuracy of tumor targeting in cancer treatments. The project involves collaboration between Weill Cornell Medicine and an industrial partner to develop this advanced imaging tool, which could lead to earlier diagnosis and more effective therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with neurological diseases such as Alzheimer's or those with brain tumors requiring imaging for treatment planning.
Not a fit: Patients with conditions unrelated to neurological diseases or brain tumors may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection and more precise treatment options for patients with neurological disorders and brain tumors.
How similar studies have performed: Previous advancements in brain imaging technologies have shown promise, suggesting that this approach could lead to significant improvements in patient outcomes.
Where this research is happening
NEW YORK, UNITED STATES
- WEILL MEDICAL COLL OF CORNELL UNIV — NEW YORK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: NEHMEH, SADEK — WEILL MEDICAL COLL OF CORNELL UNIV
- Study coordinator: NEHMEH, SADEK
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Alzheimer disease dementia, Alzheimer syndrome, Alzheimer's Disease